{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:08:32Z","timestamp":1776092912519,"version":"3.50.1"},"reference-count":209,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2014.00142","type":"journal-article","created":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T10:34:53Z","timestamp":1409567693000},"source":"Crossref","is-referenced-by-count":28,"title":["Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System"],"prefix":"10.3389","volume":"5","author":[{"given":"Jonathan","family":"Janssens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harmonie","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif","family":"Idriss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelkrim","family":"Azmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwen","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Maudsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,9,1]]},"reference":[{"issue":"2","key":"B1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1124\/jpet.105.083121","article-title":"The origins of diversity and specificity in G protein-coupled receptor signaling","volume":"314","author":"Maudsley","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"B2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2125.2003.02046.x","article-title":"Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology","volume":"57","author":"Brink","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0014-5793(02)02775-8","article-title":"Identification of G protein-coupled receptor genes from the human genome sequence","volume":"520","author":"Takeda","year":"2002","journal-title":"FEBS Lett"},{"key":"B4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-60761-495-1_5","article-title":"The devil is in the dose: complexity of receptor systems and responses","volume-title":"Hormesis: A Revolution in Biology, Toxicology and Medicine","author":"Chadwick","year":"2010"},{"issue":"5","key":"B5","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1124\/mol.104.009001","article-title":"The repertoire of G-protein-coupled receptors in fully sequenced genomes","volume":"67","author":"Fredriksson","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"1","key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/156720507779939850","article-title":"G protein-coupled receptor signaling complexity in neuronal tissue: implications for novel therapeutics","volume":"4","author":"Maudsley","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/B978-0-12-385952-5.00001-4","article-title":"GPCR-interacting proteins, major players of GPCR function","volume":"62","author":"Maurice","year":"2011","journal-title":"Adv Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/B978-0-12-394440-5.00017-6","article-title":"Systems analysis of arrestin pathway functions","volume":"118","author":"Maudsley","year":"2013","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"2","key":"B9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1210\/me.2012-1091","article-title":"\u00ce\u00b2-arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivo","volume":"27","author":"Gesty-Palmer","year":"2013","journal-title":"Mol Endocrinol"},{"issue":"9","key":"B10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2174\/138955712800959071","article-title":"Functional signaling biases in G protein-coupled receptors: game theory and receptor dynamics","volume":"12","author":"Maudsley","year":"2012","journal-title":"Mini Rev Med Chem"},{"key":"B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/B978-0-12-385952-5.00009-9","article-title":"Refining efficacy: exploiting functional selectivity for drug discovery","volume":"62","author":"Gesty-Palmer","year":"2011","journal-title":"Adv Pharmacol"},{"issue":"20","key":"B12","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.1158\/0008-5472.CAN-04-1360","article-title":"Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor","volume":"64","author":"Maudsley","year":"2004","journal-title":"Cancer Res"},{"issue":"1\u00e2\u20ac\u201c2","key":"B13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/10799890801941921","article-title":"Heptahelical terpsichory. Who calls the tune?","volume":"28","author":"Gesty-Palmer","year":"2008","journal-title":"J Recept Signal Transduct Res"},{"issue":"5","key":"B14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2174\/187152710793361559","article-title":"Gonadotropin-releasing hormone receptor system: modulatory role in aging and neurodegeneration","volume":"9","author":"Wang","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"3","key":"B15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000342694","article-title":"Correlated evolution of gonadotropin-releasing hormone and gonadotropin-inhibitory hormone and their receptors in mammals","volume":"97","author":"Tiwary","year":"2013","journal-title":"Neuroendocrinology"},{"issue":"1","key":"B16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygcen.2010.10.018","article-title":"Revisiting the evolution of gonadotropin-releasing hormones and their receptors in vertebrates: secrets hidden in genomes","volume":"170","author":"Kim","year":"2011","journal-title":"Gen Comp Endocrinol"},{"issue":"1\u00e2\u20ac\u201c2","key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2004.07.015","article-title":"Ghrelin and reproduction: a novel signal linking energy status and fertility?","volume":"226","author":"Barreiro","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"B18","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/JOE-13-0227","article-title":"The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis","volume":"219","author":"O\u00e2\u20ac\u2122Carroll","year":"2013","journal-title":"J Endocrinol"},{"issue":"5","key":"B19","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1210\/en.2011-2117","article-title":"Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks","volume":"153","author":"Pi","year":"2012","journal-title":"Endocrinology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"147825","DOI":"10.1155\/2012\/147825","article-title":"New cardiovascular and pulmonary therapeutic strategies based on the angiotensin-converting enzyme 2\/angiotensin-(1-7)\/mas receptor axis","volume":"2012","author":"Ferreira","year":"2012","journal-title":"Int J Hypertens"},{"issue":"24","key":"B21","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1002\/elps.201200360","article-title":"Use of proteomic methods in the analysis of human body fluids in Alzheimer research","volume":"33","author":"Zurbig","year":"2012","journal-title":"Electrophoresis"},{"issue":"2","key":"B22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/0019-557X.85234","article-title":"Make dementia a public health priority in India","volume":"55","author":"Sinha","year":"2011","journal-title":"Indian J Public Health"},{"issue":"4","key":"B23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat Med"},{"key":"B24","volume-title":"World Alzheimer\u00e2\u20ac\u2122s Report 2009","author":"Ferri","year":"2009"},{"issue":"7","key":"B25","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jprot.2011.03.033","article-title":"Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer\u00e2\u20ac\u2122s disease subjects","volume":"74","author":"Di Domenico","year":"2011","journal-title":"J Proteomics"},{"issue":"38","key":"B26","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.2174\/13816128113199990612","article-title":"Metabolic basis of sporadic Alzheimer\u00e2\u20ac\u2122s disease. Role of hormones related to energy metabolism","volume":"19","author":"Folch","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"1","key":"B27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/156720512799015064","article-title":"Metabolic dysfunction in Alzheimer\u00e2\u20ac\u2122s disease and related neurodegenerative disorders","volume":"9","author":"Cai","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.jprot.2010.08.008","article-title":"Proteasome and oxidative phoshorylation changes may explain why aging is a risk factor for neurodegenerative disorders","volume":"73","author":"Zabel","year":"2010","journal-title":"J Proteomics"},{"issue":"8","key":"B29","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1515\/cclm-2011-0550","article-title":"Application of matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in Alzheimer\u00e2\u20ac\u2122s disease","volume":"50","author":"Grela","year":"2012","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"B30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neurobiolaging.2003.12.016","article-title":"Alzheimer\u00e2\u20ac\u2122s disease \u00e2\u20ac\u201c a sum greater than its parts?","volume":"25","author":"Adlard","year":"2004","journal-title":"Neurobiol Aging"},{"issue":"77","key":"B31","doi-asserted-by":"publisher","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u00e2\u20ac\u2122s disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci Transl Med"},{"issue":"6","key":"B32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00401-012-1061-x","article-title":"APP mutations in the Abeta coding region are associated with abundant cerebral deposition of Abeta38","volume":"124","author":"Moro","year":"2012","journal-title":"Acta Neuropathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"604792","DOI":"10.4061\/2010\/604792","article-title":"Complex and multidimensional lipid raft alterations in a murine model of Alzheimer\u00e2\u20ac\u2122s disease","volume":"2010","author":"Chadwick","year":"2010","journal-title":"Int J Alzheimers Dis"},{"issue":"6","key":"B34","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/jnr.22603","article-title":"Peripheral reduction of beta-amyloid is sufficient to reduce brain beta-amyloid: implications for Alzheimer\u00e2\u20ac\u2122s disease","volume":"89","author":"Sutcliffe","year":"2011","journal-title":"J Neurosci Res"},{"issue":"2","key":"B35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JAD-121168","article-title":"Metabolic syndrome and cognitive decline in early Alzheimer\u00e2\u20ac\u2122s disease and healthy older adults","volume":"35","author":"Watts","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"B36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11892-014-0487-z","article-title":"Diabetes mellitus and dementia","volume":"14","author":"Ninomiya","year":"2014","journal-title":"Curr Diab Rep"},{"issue":"5 Pt 1","key":"B37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S1262-3636(07)70298-7","article-title":"Diabetes mellitus and dementia","volume":"32","author":"Pasquier","year":"2006","journal-title":"Diabetes Metab"},{"issue":"6","key":"B38","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer\u00e2\u20ac\u2122s disease is type 3 diabetes-evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"B39","doi-asserted-by":"crossref","first-page":"F625","DOI":"10.1152\/ajprenal.00140.2005","article-title":"A causal role for uric acid in fructose-induced metabolic syndrome","volume":"290","author":"Nakagawa","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"B40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00702-010-0426-3","article-title":"The link between iron, metabolic syndrome, and Alzheimer\u00e2\u20ac\u2122s disease","volume":"118","author":"Grunblatt","year":"2011","journal-title":"J Neural Transm"},{"issue":"3\u00e2\u20ac\u201c4","key":"B41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.brainresbull.2012.08.003","article-title":"Metabolic syndrome, mild cognitive impairment and Alzheimer\u00e2\u20ac\u2122s disease \u00e2\u20ac\u201c the emerging role of systemic low-grade inflammation and adiposity","volume":"89","author":"Misiak","year":"2012","journal-title":"Brain Res Bull"},{"key":"B42","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/emmm.201200243","article-title":"Modification of g-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer\u00e2\u20ac\u2122s disease","volume":"4","author":"Guix","year":"2012","journal-title":"EMBO Mol Med"},{"issue":"12","key":"B43","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1253\/circj.CJ-11-1184","article-title":"Chronic inflammation links cardiovascular, metabolic and renal diseases","volume":"75","author":"Manabe","year":"2011","journal-title":"Circ J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2011.01.030","article-title":"Morphological changes in the enteric nervous system of aging and APP23 transgenic mice","volume":"1378","author":"Van Ginneken","year":"2011","journal-title":"Brain Res"},{"issue":"1","key":"B45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3233\/JAD-120511","article-title":"Changes of the enteric nervous system in amyloid-\u00ce\u00b2 protein precursor transgenic mice correlate with disease progression","volume":"36","author":"Semar","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"22","key":"B46","doi-asserted-by":"publisher","first-page":"18820","DOI":"10.1074\/jbc.M111.331181","article-title":"Amyloid beta (Abeta) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways","volume":"287","author":"Fu","year":"2012","journal-title":"J Biol Chem"},{"issue":"5","key":"B47","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/MCO.0b013e32829fb37c","article-title":"Influence of ghrelin on food intake and energy homeostasis","volume":"10","author":"De Vriese","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"B48","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s12603-012-0058-4","article-title":"Ghrelin and leptin secretion in patients with moderate Alzheimer\u00e2\u20ac\u2122s disease","volume":"16","author":"Theodoropoulou","year":"2012","journal-title":"J Nutr Health Aging"},{"issue":"3","key":"B49","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3233\/JAD-2010-100873","article-title":"Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer\u00e2\u20ac\u2122s disease patients","volume":"22","author":"Gahete","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"B50","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/WAD.0b013e31820ce536","article-title":"Ghrelin-attenuated cognitive dysfunction in streptozotocin-induced diabetic rats","volume":"25","author":"Ma","year":"2011","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"B51","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.2000.278.1.E1","article-title":"The adipoinsular axis: effects of leptin on pancreatic beta-cells","volume":"278","author":"Kieffer","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI1411","article-title":"Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1\/SREBP1","volume":"101","author":"Kim","year":"1998","journal-title":"J Clin Invest"},{"issue":"4\u00e2\u20ac\u201c5","key":"B53","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s11064-006-9125-8","article-title":"Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer\u00e2\u20ac\u2122s dementia","volume":"32","author":"Giordano","year":"2007","journal-title":"Neurochem Res"},{"issue":"4","key":"B54","first-page":"197","article-title":"Evidence of endothelial dysfunction in the development of Alzheimer\u00e2\u20ac\u2122s disease: is Alzheimer\u00e2\u20ac\u2122s a vascular disorder?","volume":"3","author":"Kelleher","year":"2013","journal-title":"Am J Cardiovasc Dis"},{"issue":"6570","key":"B55","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/380168a0","article-title":"Beta-amyloid-mediated vasoactivity and vascular endothelial damage","volume":"380","author":"Thomas","year":"1996","journal-title":"Nature"},{"issue":"2","key":"B56","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1006\/excr.1996.3440","article-title":"Beta-amyloid-induced endothelial necrosis and inhibition of nitric oxide production","volume":"230","author":"Sutton","year":"1997","journal-title":"Exp Cell Res"},{"issue":"10","key":"B57","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood-brain barrier dysfunction as a cause and consequence of Alzheimer\u00e2\u20ac\u2122s disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"B58","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMra1106180","article-title":"Proteotoxicity and cardiac dysfunction \u00e2\u20ac\u201c Alzheimer\u00e2\u20ac\u2122s disease of the heart?","volume":"368","author":"Willis","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"B59","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.biopsych.2012.11.021","article-title":"The circadian system in Alzheimer\u00e2\u20ac\u2122s disease: disturbances, mechanisms, and opportunities","volume":"74","author":"Coogan","year":"2013","journal-title":"Biol Psychiatry"},{"key":"B60","doi-asserted-by":"publisher","first-page":"S683","DOI":"10.1016\/j.euroneuro.2011.07.008","article-title":"Circadian rhythms and mood regulation: insights from pre-clinical models","volume":"21","author":"McClung","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"B61","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/ana.22468","article-title":"Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women","volume":"70","author":"Tranah","year":"2011","journal-title":"Ann Neurol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nature00965","article-title":"Coordination of circadian timing in mammals","volume":"418","author":"Reppert","year":"2002","journal-title":"Nature"},{"issue":"7","key":"B63","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1080\/10408398.2011.559557","article-title":"Aroma and taste perceptions with Alzheimer disease and stroke","volume":"53","author":"Aliani","year":"2013","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"6","key":"B64","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ejpain.2010.10.010","article-title":"The impact of Alzheimer\u00e2\u20ac\u2122s disease on the functional connectivity between brain regions underlying pain perception","volume":"15","author":"Cole","year":"2011","journal-title":"Eur J Pain"},{"issue":"1","key":"B65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbr.2012.02.044","article-title":"Age-related changes in visual acuity, learning and memory in the APPswe\/PS1dE9 mouse model of Alzheimer\u00e2\u20ac\u2122s disease","volume":"231","author":"Stover","year":"2012","journal-title":"Behav Brain Res"},{"issue":"4","key":"B66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.maturitas.2014.01.003","article-title":"Considering the senses in the diagnosis and management of dementia","volume":"77","author":"Behrman","year":"2014","journal-title":"Maturitas"},{"issue":"2","key":"B67","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00415-009-5300-6","article-title":"Taste in mild cognitive impairment and Alzheimer\u00e2\u20ac\u2122s disease","volume":"257","author":"Steinbach","year":"2010","journal-title":"J Neurol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","article-title":"Range of neuropsychiatric disturbances in patients with Parkinson\u00e2\u20ac\u2122s disease","volume":"67","author":"Aarsland","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrneurol.2013.132","article-title":"Advances in the genetics of Parkinson disease","volume":"9","author":"Trinh","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1111\/febs.12335","article-title":"The hallmarks of Parkinson\u00e2\u20ac\u2122s disease","volume":"280","author":"Antony","year":"2013","journal-title":"FEBS J"},{"key":"B71","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jprot.2009.07.007","article-title":"Proteomics in human Parkinson\u00e2\u20ac\u2122s disease research","volume":"73","author":"Licker","year":"2009","journal-title":"J Proteomics"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1172\/JCI29178","article-title":"Diagnosis and treatment of Parkinson disease: molecules to medicine","volume":"116","author":"Savitt","year":"2006","journal-title":"J Clin Invest"},{"key":"B74","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u00e2\u20ac\u2122s disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2011.04.012","article-title":"Synuclein deposition and non-motor symptoms in Parkinson disease","volume":"310","author":"Jellinger","year":"2011","journal-title":"J Neurol Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.brainresbull.2009.06.018","article-title":"Neuropathology of Lewy body disorders","volume":"80","author":"Kovari","year":"2009","journal-title":"Brain Res Bull"},{"issue":"S3","key":"B77","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1016\/S1353-8020(08)70005-1","article-title":"Neuropathology of Parkinson\u00e2\u20ac\u2122s disease dementia and dementia with Lewy bodies with reference to striatal pathology","volume":"13","author":"Tsuboi","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"issue":"S3","key":"B78","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1353-8020(09)70769-2","article-title":"Neuropathology of non-motor features of Parkinson disease","volume":"15","author":"Dickson","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"B79","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1212\/WNL.0b013e318236ef60","article-title":"Parkinson disease: the enteric nervous system spills its guts","volume":"77","author":"Derkinderen","year":"2011","journal-title":"Neurology"},{"issue":"S2","key":"B81","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000113469","article-title":"Neuropathology of autonomic nervous system in Parkinson\u00e2\u20ac\u2122s disease","volume":"38","author":"Wakabayashi","year":"1997","journal-title":"Eur Neurol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u00e2\u20ac\u2122s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"B83","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","article-title":"Olfactory dysfunction in Parkinson disease","volume":"8","author":"Doty","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/ana.20160","article-title":"Idiopathic hyposmia as a preclinical sign of Parkinson\u00e2\u20ac\u2122s disease","volume":"56","author":"Ponsen","year":"2004","journal-title":"Ann Neurol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF00697388","article-title":"Loss of neurons in the nucleus basalis of Meynert in Alzheimer\u00e2\u20ac\u2122s disease, paralysis agitans and Korsakoff\u00e2\u20ac\u2122s Disease","volume":"61","author":"Arendt","year":"1983","journal-title":"Acta Neuropathol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/nn.2335","article-title":"Serotonergic modulation of odor input to the mammalian olfactory bulb","volume":"12","author":"Petzold","year":"2009","journal-title":"Nat Neurosci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch Neurol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11910-011-0204-0","article-title":"Gastrointestinal features of Parkinson\u00e2\u20ac\u2122s disease","volume":"11","author":"Cloud","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","article-title":"Medical records documentation of constipation preceding Parkinson disease: a case-control study","volume":"73","author":"Savica","year":"2009","journal-title":"Neurology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.nbd.2011.10.014","article-title":"Pathological correlates of gastrointestinal dysfunction in Parkinson\u00e2\u20ac\u2122s disease","volume":"46","author":"Cersosimo","year":"2012","journal-title":"Neurobiol Dis"},{"key":"B91","doi-asserted-by":"publisher","first-page":"924605","DOI":"10.4061\/2011\/924605","article-title":"Bladder, bowel, and sexual dysfunction in Parkinson\u00e2\u20ac\u2122s disease","volume":"2011","author":"Sakakibara","year":"2011","journal-title":"Parkinsons Dis"},{"issue":"2","key":"B92","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.expneurol.2008.10.007","article-title":"Diminished iron concentrations increase adenosine A(2A) receptor levels in mouse striatum and cultured human neuroblastoma cells","volume":"215","author":"Gulyani","year":"2009","journal-title":"Exp Neurol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1212\/WNL.51.2.363","article-title":"REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease","volume":"51","author":"Boeve","year":"1998","journal-title":"Neurology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11910-013-0377-9","article-title":"Cholinergic dysfunction in Parkinson\u00e2\u20ac\u2122s disease","volume":"13","author":"Muller","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1212\/01.wnl.0000278114.14096.74","article-title":"REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia","volume":"69","author":"Vendette","year":"2007","journal-title":"Neurology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/cphy.c130026","article-title":"Dysautonomia in Parkinson disease","volume":"4","author":"Goldstein","year":"2014","journal-title":"Compr Physiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nbd.2011.10.025","article-title":"Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis","volume":"46","author":"Jain","year":"2012","journal-title":"Neurobiol Dis"},{"key":"B98","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","article-title":"Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson\u00e2\u20ac\u2122s disease","volume":"17","author":"Orimo","year":"2007","journal-title":"Brain Pathol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/brain\/awm302","article-title":"Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u00e2\u20ac\u2122s disease","volume":"131","author":"Orimo","year":"2008","journal-title":"Brain"},{"key":"B100","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/jnr.490270408","article-title":"6-[18F]fluoro-l-dopa probes dopamine turnover rates in central dopaminergic structures","volume":"27","author":"Barrio","year":"1990","journal-title":"J Neurosci Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/mds.22649","article-title":"MIBG scintigraphy for differentiating Parkinson\u00e2\u20ac\u2122s disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy","volume":"24","author":"Chung","year":"2009","journal-title":"Mov Disord"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1212\/01.wnl.0000335246.93495.92","article-title":"The arterial baroreflex: functional organization and involvement in neurologic disease","volume":"71","author":"Benarroch","year":"2008","journal-title":"Neurology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.parkreldis.2011.05.020","article-title":"The prevalence of symptomatic orthostatic hypotension in patients with Parkinson\u00e2\u20ac\u2122s disease and atypical parkinsonism","volume":"17","author":"Ha","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"B104","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch Neurol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2337\/dc10-1922","article-title":"Diabetes and risk of Parkinson\u00e2\u20ac\u2122s disease","volume":"34","author":"Xu","year":"2011","journal-title":"Diabetes Care"},{"key":"B106","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/brain\/aws009","article-title":"Parkinson\u00e2\u20ac\u2122s disease, insulin resistance and novel agents of neuroprotection","volume":"136","author":"Aviles-Olmos","year":"2013","journal-title":"Brain"},{"key":"B107","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.molmed.2013.01.002","article-title":"Shared dysregulated pathways lead to Parkinson\u00e2\u20ac\u2122s disease and diabetes","volume":"19","author":"Santiago","year":"2013","journal-title":"Trends Mol Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0301-0082(91)90015-S","article-title":"Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects","volume":"36","author":"Unger","year":"1991","journal-title":"Prog Neurobiol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1471-4159.2008.05406.x","article-title":"Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2\/D3 receptor activation","volume":"106","author":"Bellucci","year":"2008","journal-title":"J Neurochem"},{"issue":"6","key":"B110","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1471-4159.2010.07168.x","article-title":"Effects of neuroinflammation on the regenerative capacity of brain stem cells","volume":"116","author":"Russo","year":"2011","journal-title":"J Neurochem"},{"key":"B111","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.expneurol.2012.12.008","article-title":"Commentary: progressive inflammation as a contributing factor to early development of Parkinson\u00e2\u20ac\u2122s disease","volume":"241","author":"Pradhan","year":"2013","journal-title":"Exp Neurol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-2094-11-52","article-title":"LRRK2 and neuroinflammation: partners in crime in Parkinson\u00e2\u20ac\u2122s disease?","volume":"11","author":"Russo","year":"2014","journal-title":"J Neuroinflammation"},{"issue":"6","key":"B113","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1440-1681.2011.05650.x","article-title":"Targeting metabolic inflammation in Parkinson\u00e2\u20ac\u2122s disease: implications for prospective therapeutic strategies","volume":"39","author":"Lu","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"B114","first-page":"237","article-title":"Therapeutic perspectives for the treatment of Huntington\u00e2\u20ac\u2122s disease: treating the whole body","volume":"23","author":"Martin","year":"2008","journal-title":"Histol Histopathol"},{"issue":"6","key":"B115","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u00e2\u20ac\u2122s disease chromosomes. The Huntington\u00e2\u20ac\u2122s Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"issue":"5529","key":"B116","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington\u00e2\u20ac\u2122s disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"issue":"5","key":"B117","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1242\/jcs.115.5.941","article-title":"Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington\u00e2\u20ac\u2122s disease","volume":"115","author":"Hoffner","year":"2002","journal-title":"J Cell Sci"},{"issue":"5","key":"B118","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"issue":"1","key":"B119","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/exnr.1998.6832","article-title":"Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways","volume":"152","author":"Velier","year":"1998","journal-title":"Exp Neurol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.expneurol.2012.10.014","article-title":"Circadian and sleep disorder in Huntington\u00e2\u20ac\u2122s disease","volume":"243","author":"Morton","year":"2013","journal-title":"Exp Neurol"},{"issue":"11","key":"B121","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1136\/jnnp.2009.191833","article-title":"Systemic energy homeostasis in Huntington\u00e2\u20ac\u2122s disease patients","volume":"81","author":"Aziz","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"B122","doi-asserted-by":"publisher","first-page":"e47240","DOI":"10.1371\/journal.pone.0047240","article-title":"Altered hypothalamic protein expression in a rat model of Huntington\u00e2\u20ac\u2122s disease","volume":"7","author":"Cong","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"B123","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00415-009-5196-1","article-title":"Delayed onset of the diurnal melatonin rise in patients with Huntington\u00e2\u20ac\u2122s disease","volume":"256","author":"Aziz","year":"2009","journal-title":"J Neurol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","article-title":"Diabetes mellitus in Huntington disease","volume":"27","author":"Farrer","year":"1985","journal-title":"Clin Genet"},{"issue":"1","key":"B125","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","article-title":"Altered cholesterol and fatty acid metabolism in Huntington disease","volume":"4","author":"Dorsey","year":"2010","journal-title":"J Clin Lipidol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00221-005-2357-z","article-title":"Atypical diabetes associated with inclusion formation in the R6\/2 mouse model of Huntington\u00e2\u20ac\u2122s disease is not improved by treatment with hypoglycaemic agents","volume":"166","author":"Hunt","year":"2005","journal-title":"Exp Brain Res"},{"issue":"4","key":"B127","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion","volume":"65","author":"Lalic","year":"2008","journal-title":"Arch Neurol"},{"issue":"7","key":"B128","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/archneur.62.7.1067","article-title":"Insulin resistance in cognitive impairment: the InCHIANTI study","volume":"62","author":"Geroldi","year":"2005","journal-title":"Arch Neurol"},{"issue":"4","key":"B129","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","article-title":"Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits","volume":"13","author":"Hult","year":"2011","journal-title":"Cell Metab"},{"issue":"1","key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2011.05.006","article-title":"Gastrointestinal dysfunction contributes to weight loss in Huntington\u00e2\u20ac\u2122s disease mice","volume":"44","author":"van der Burg","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"1","key":"B131","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.expneurol.2010.12.011","article-title":"Dysfunctions in circadian behavior and physiology in mouse models of Huntington\u00e2\u20ac\u2122s disease","volume":"228","author":"Kudo","year":"2011","journal-title":"Exp Neurol"},{"issue":"1","key":"B132","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","article-title":"Disintegration of the sleep-wake cycle and circadian timing in Huntington\u00e2\u20ac\u2122s disease","volume":"25","author":"Morton","year":"2005","journal-title":"J Neurosci"},{"issue":"29","key":"B133","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1523\/JNEUROSCI.0649-07.2007","article-title":"Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington\u00e2\u20ac\u2122s disease","volume":"27","author":"Pallier","year":"2007","journal-title":"J Neurosci"},{"key":"B134","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.brainres.2009.03.072","article-title":"Management of sleep\/wake cycles improves cognitive function in a transgenic mouse model of Huntington\u00e2\u20ac\u2122s disease","volume":"1279","author":"Pallier","year":"2009","journal-title":"Brain Res"},{"issue":"30","key":"B135","doi-asserted-by":"publisher","first-page":"10199","DOI":"10.1523\/JNEUROSCI.1694-10.2010","article-title":"Disruption of peripheral circadian timekeeping in a mouse model of Huntington\u00e2\u20ac\u2122s disease and its restoration by temporally scheduled feeding","volume":"30","author":"Maywood","year":"2010","journal-title":"J Neurosci"},{"key":"B136","volume-title":"Huntington\u00e2\u20ac\u2122s Disease","year":"2002","edition":"Third ed"},{"issue":"Suppl 16","key":"B137","first-page":"27","article-title":"Daytime sleepiness and insomnia as correlates of depression","volume":"65","author":"Fava","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"B138","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0889-1591(03)00078-3","article-title":"Circadian disruption in cancer: a neuroendocrine immune pathway from stress to disease?","volume":"17","author":"Sephton","year":"2003","journal-title":"Brain Behav Immun"},{"key":"B139","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-141-11-200412070-00008","article-title":"Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite","volume":"7","author":"Spiegel","year":"2004","journal-title":"Ann Intern Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.psyneuen.2009.12.011","article-title":"Circadian effects in cancer relevant psychoneuroendocrine and immune pathways","volume":"35","author":"Eismann","year":"2010","journal-title":"Psychoneuroendocrinology"},{"issue":"Pt 22","key":"B141","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1113\/jphysiol.2012.238113","article-title":"Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington\u00e2\u20ac\u2122s disease","volume":"590","author":"Kiriazis","year":"2012","journal-title":"J Physiol"},{"issue":"1","key":"B142","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JHD-130083","article-title":"Right ventricular dysfunction in the R6\/2 transgenic mouse model of Huntington\u00e2\u20ac\u2122s disease is unmasked by dobutamine","volume":"3","author":"Buonincontri","year":"2014","journal-title":"J Huntingtons Dis"},{"key":"B143","doi-asserted-by":"publisher","first-page":"RRN1266","DOI":"10.1371\/currents.RRN1266","article-title":"Baroreceptor reflex dysfunction in the BACHD mouse model of Huntington\u00e2\u20ac\u2122s disease","volume":"3","author":"Schroeder","year":"2011","journal-title":"PLoS Curr"},{"key":"B144","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington\u00e2\u20ac\u2122s disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.107.750232","article-title":"Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure","volume":"117","author":"Pattison","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"B146","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u00e2\u20ac\u2122s disease","volume":"205","author":"Bj\u00c3\u00b6rkqvist","year":"2008","journal-title":"J Exp Med"},{"issue":"12","key":"B147","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1172\/JCI64484","article-title":"Mutant huntingtin impairs immune cell migration in Huntington disease","volume":"122","author":"Kwan","year":"2012","journal-title":"J Clin Invest"},{"key":"B148","doi-asserted-by":"publisher","first-page":"RRN1231","DOI":"10.1371\/currents.RRN1231","article-title":"Abnormal peripheral chemokine profile in Huntington\u00e2\u20ac\u2122s disease","volume":"3","author":"Wild","year":"2011","journal-title":"PLoS Curr"},{"issue":"16","key":"B149","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","article-title":"Inhibition of soluble tumor necrosis factor is therapeutic in Huntington\u00e2\u20ac\u2122s disease","volume":"23","author":"Hsiao","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"3","key":"B150","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1017\/S1355617708080405","article-title":"Visual perception in prediagnostic and early stage Huntington\u00e2\u20ac\u2122s disease","volume":"14","author":"O\u00e2\u20ac\u2122Donnell","year":"2008","journal-title":"J Int Neuropsychol Soc"},{"issue":"3","key":"B151","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/hbm.21449","article-title":"Clinical impairment in premanifest and early Huntington\u00e2\u20ac\u2122s disease is associated with regionally specific atrophy","volume":"34","author":"Scahill","year":"2013","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"B152","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1176\/appi.neuropsych.17.1.119","article-title":"Huntington\u00e2\u20ac\u2122s disease patients show impaired perception of disgust in the gustatory and olfactory modalities","volume":"17","author":"Mitchell","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"B153","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/1073858407312382","article-title":"Defects in tongue papillae and taste sensation indicate a problem with neurotrophic support in various neurological diseases","volume":"14","author":"Gardiner","year":"2008","journal-title":"Neuroscientist"},{"issue":"2","key":"B154","doi-asserted-by":"publisher","first-page":"E538","DOI":"10.1152\/ajpendo.00070.2007","article-title":"Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets","volume":"293","author":"Zhou","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B155","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1677\/joe.0.1380159","article-title":"Glucagon-like peptide-1(7\u00e2\u20ac\u201c36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns","volume":"138","author":"Elliott","year":"1993","journal-title":"J Endocrionol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.2337\/diabetes.42.11.1678","article-title":"Cloning and functional expression of the human islet GLP-1 receptor: demonstration that exendin-4 is an agonist and exendin-(9\u00e2\u20ac\u201c39) an antagonist of the receptor","volume":"42","author":"Thorens","year":"1993","journal-title":"Diabetes"},{"key":"B157","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pharmthera.2009.07.006","article-title":"Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies","volume":"125","author":"Chapter","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"1\u00e2\u20ac\u201c2","key":"B158","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1385\/NMM:7:1-2:003","article-title":"Class II G protein-coupled receptors and their ligands in neuronal function and protection","volume":"7","author":"Martin","year":"2005","journal-title":"Neuromolecular Med"},{"issue":"18","key":"B159","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1073\/pnas.0710402105","article-title":"Beta-arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells","volume":"105","author":"Sonoda","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"B160","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/MED.0b013e32834ea723","article-title":"Gastrointestinal regulatory peptides and central nervous system mechanisms of weight control","volume":"19","author":"Ladenheim","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B161","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000358322","article-title":"What is the role of metabolic hormones in taste buds of the tongue","volume":"42","author":"Cai","year":"2014","journal-title":"Front Horm Res"},{"issue":"2","key":"B162","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1124\/jpet.103.063222","article-title":"Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration","volume":"309","author":"Banks","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"B163","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-13-0414","article-title":"Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS","volume":"221","author":"van Bloemendaal","year":"2014","journal-title":"J Endocrinol"},{"issue":"3","key":"B164","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1124\/jpet.110.166470","article-title":"Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides","volume":"334","author":"Kim","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"B165","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1111\/j.1749-6632.2012.06491.x","article-title":"Update on incretin hormones","volume":"1243","author":"Phillips","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"B166","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2967\/jnumed.106.038679","article-title":"GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting","volume":"48","author":"K\u00c3\u00b6rner","year":"2007","journal-title":"J Nucl Med"},{"issue":"10","key":"B167","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2165\/11635890-000000000-00000","article-title":"Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection","volume":"26","author":"H\u00c3\u00b6lscher","year":"2012","journal-title":"CNS Drugs"},{"issue":"2","key":"B168","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2337\/db08-0799","article-title":"Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington\u00e2\u20ac\u2122s disease","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes"},{"issue":"11\u00e2\u20ac\u201c12","key":"B169","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1055\/s-2004-826173","article-title":"GLP-1 and extra-islet effects","volume":"36","author":"Ahr\u00c3\u00a9n","year":"2004","journal-title":"Horm Metab Res"},{"issue":"5","key":"B170","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/gerona\/glt129","article-title":"Longitudinal analysis of calorie restriction on rat taste bud morphology and expression of sweet taste modulators","volume":"69","author":"Cai","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"B171","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11892-014-0483-3","article-title":"Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy","volume":"14","author":"Avogaro","year":"2014","journal-title":"Curr Diab Rep"},{"issue":"10","key":"B172","doi-asserted-by":"publisher","first-page":"E1105","DOI":"10.1152\/ajpendo.00529.2012","article-title":"Effects of prolonged exendin-4 administration on hypothalamic-pituitary-adrenal axis activity and water balance","volume":"304","author":"Gil-Lozano","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"B173","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/01677063.2011.628426","article-title":"Pharmacological validation of candidate causal sleep genes identified in an N2 cross","volume":"25","author":"Brunner","year":"2011","journal-title":"J Neurogenet"},{"issue":"38","key":"B174","doi-asserted-by":"publisher","first-page":"31766","DOI":"10.1074\/jbc.M112.387316","article-title":"Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy","volume":"287","author":"Martin","year":"2012","journal-title":"J Biol Chem"},{"issue":"4","key":"B175","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.bbadis.2013.01.008","article-title":"Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration","volume":"1832","author":"Duarte","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"B176","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1172\/JCI68295","article-title":"Exenatide and the treatment of patients with Parkinson\u00e2\u20ac\u2122s disease","volume":"123","author":"Aviles-Olmos","year":"2013","journal-title":"J Clin Invest"},{"key":"B177","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuroscience.2013.10.038","article-title":"Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation","volume":"256","author":"Chen","year":"2014","journal-title":"Neuroscience"},{"issue":"1S","key":"B178","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jalz.2013.12.009","article-title":"The incretin hormones glucagon like peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer\u00e2\u20ac\u2122s disease","volume":"10","author":"H\u00c3\u00b6lscher","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"20","key":"B179","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.1158\/0008-5472.CAN-04-1360","article-title":"Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor","volume":"64","author":"Maudsley","year":"2004","journal-title":"Cancer Res"},{"issue":"9548","key":"B180","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"B181","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1021\/jm9909645","article-title":"Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration","volume":"43","author":"Knudsen","year":"2000","journal-title":"J Med Chem"},{"key":"B182","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/bc049735+","article-title":"Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1","volume":"16","author":"Lee","year":"2005","journal-title":"Bioconjug Chem"},{"key":"B183","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1046\/j.1365-2362.1999.00440.x","article-title":"Comparison of the effect of native glucagon-like peptide 1 and dipeptidyl peptidase IV-resistant analogues on insulin release from rat pancreatic islets","volume":"29","author":"Siegel","year":"1999","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"B184","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.regpep.2003.10.028","article-title":"Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes","volume":"117","author":"Nielsen","year":"2004","journal-title":"Regul Pept"},{"issue":"7","key":"B185","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s12272-011-0721-z","article-title":"The development of non-peptide glucagon-like peptide-1 receptor agonist for the treatment of type 2 diabetes","volume":"34","author":"Moon","year":"2011","journal-title":"Arch Pharm Res"},{"issue":"6","key":"B186","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1177\/1087057114520971","article-title":"A duplexed high-throughput screen to identify allosteric modulators of the Glucagon-Like Peptide 1 and Glucagon receptors","volume":"19","author":"Morris","year":"2014","journal-title":"J Biomol Screen"},{"issue":"5","key":"B187","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12272-013-0253-9","article-title":"Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists","volume":"37","author":"Zhang","year":"2014","journal-title":"Arch Pharm Res"},{"key":"B188","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1124\/mol.110.065664","article-title":"Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening","volume":"78","author":"Koole","year":"2010","journal-title":"Mol Pharmacol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1073\/pnas.0610173104","article-title":"A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db\/db mice","volume":"104","author":"Chen","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B190","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.2337\/db10-0689","article-title":"Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets","volume":"59","author":"Sloop","year":"2010","journal-title":"Diabetes"},{"key":"B191","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1073\/pnas.0605701104","article-title":"Small-molecule agonists for the glucagon-like peptide 1 receptor","volume":"104","author":"Knudsen","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B192","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1124\/mol.112.080432","article-title":"Small molecule allosteric modulation of the glucagon-like peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin","volume":"82","author":"Willard","year":"2012","journal-title":"Mol Pharmacol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/mol.112.079319","article-title":"Allosteric modulation of endogenous metabolites as an avenue for drug discovery","volume":"82","author":"Wootten","year":"2012","journal-title":"Mol Pharmacol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1021\/jm900752a","article-title":"Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity","volume":"52","author":"Mapelli","year":"2009","journal-title":"J Med Chem"},{"issue":"8","key":"B195","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1210\/me.2013-1116","article-title":"Minireview: signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery","volume":"27","author":"Koole","year":"2013","journal-title":"Mol Endocrinol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1210\/endo.140.3.6550","article-title":"Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells","volume":"140","author":"Montrose-Rafizadeh","year":"1999","journal-title":"Endocrinology"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1074\/jbc.M109.067207","article-title":"GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a \u00ce\u00b2-arrestin 1-mediated ERK1\/2 activation in pancreatic \u00ce\u00b2-cells","volume":"285","author":"Quoyer","year":"2010","journal-title":"J Biol Chem"},{"issue":"13","key":"B198","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.1074\/jbc.275.13.9572","article-title":"The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor","volume":"275","author":"Maudsley","year":"2000","journal-title":"J Biol Chem"},{"key":"B199","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2337\/diabetes.52.1.124","article-title":"Glucagon-like peptide 1 induces pancreatic \u00ce\u00b2-cell proliferation via transactivation of the epidermal growth factor receptor","volume":"52","author":"Buteau","year":"2003","journal-title":"Diabetes"},{"key":"B200","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fphys.2013.00190","article-title":"Plurigon: three dimensional visualization and classification of high-dimensionality data","volume":"4","author":"Martin","year":"2013","journal-title":"Front Physiol"},{"issue":"4","key":"B201","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1124\/mol.112.084525","article-title":"Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands","volume":"83","author":"Wootten","year":"2013","journal-title":"Mol Pharmacol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1124\/jpet.110.166009","article-title":"Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7\u00e2\u20ac\u201c36) amide and the small-molecule ago-allosteric agent \u00e2\u20ac\u0153compound 2\u00e2\u20ac\u009d at the GLP-1 receptor","volume":"334","author":"Coopman","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"B203","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1124\/jpet.110.176362","article-title":"Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids","volume":"336","author":"Wootten","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"45","key":"B204","doi-asserted-by":"publisher","first-page":"18607","DOI":"10.1073\/pnas.1205227109","article-title":"Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery","volume":"109","author":"Harikumar","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"B205","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer\u00e2\u20ac\u2122s disease","volume":"88","author":"de la Monte","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fnagi.2014.00018","article-title":"Morphological and bioenergetic demands underlying the mitophagy in post-mitotic neurons: the pink-parkin pathway","volume":"6","author":"Amadoro","year":"2014","journal-title":"Front Aging Neurosci"},{"issue":"6180","key":"B207","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.1249161","article-title":"PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling","volume":"344","author":"Morais","year":"2014","journal-title":"Science"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.02.005","article-title":"Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?","volume":"118C","author":"Bassil","year":"2014","journal-title":"Prog Neurobiol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/978-1-4614-0653-2_19","article-title":"Neurodegeneration in diabetes mellitus","volume":"724","author":"Umegaki","year":"2012","journal-title":"Adv Exp Med Biol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T01:53:02Z","timestamp":1650073982000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2014.00142\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":209,"URL":"https:\/\/doi.org\/10.3389\/fendo.2014.00142","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}